Arkolith/Insider Trading/APGE/Form 4

Henderson Michael Thomas

Chief Executive Officer, DirectorApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed May 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2026Sell(S)19K$82.05$1.5M1.1M
May 13, 2026Sell(S)1K$82.58$111K1.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-062867) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML